Safety and performance of Orbix breast lifting system

  • Research type

    Research Study

  • Full title

    The safety and performance of the Orbix breast lifting system

  • IRAS ID

    131629

  • Contact name

    Jian Farhadi

  • Contact email

    jian.farhadi@gstt.nhs.uk

  • Sponsor organisation

    Orbix Medical LTd

  • Clinicaltrials.gov Identifier

    NCT00774059

  • Research summary

    Several surgical methods exist for correction of breast position, all involve open breast surgery, require general anesthesia, are time consuming and involve extensive intervention and significant scarring on the skin and inside the breast tissue. A need for simpler methods is currently acknowledged among plastic surgeons. The objective of the study is to evaluate the safety and performance of the ORBIX Breast Lifting System, during breast reduction, correction of breast position and during breast augmentation in open and minimally invasive breast surgeries.
    The ORBIX Breast Lifting System is a minimally invasive technique which is intended to enable performance of such surgery using local or regional anesthesia, and without the need for an open surgery. Scarring after the ORBIX procedure is expected to be attenuated, as a result of the minimally invasive nature of the procedure.
    This is an open-label prospective study for subjects of 20 years or older. Follow-up evaluation will be performed up to 5 years post surgery.

  • REC name

    London - Chelsea Research Ethics Committee

  • REC reference

    13/LO/1648

  • Date of REC Opinion

    13 Dec 2013

  • REC opinion

    Further Information Favourable Opinion